Bicara Therapeutics (BCAX) Q2 2026 Earnings

May 11Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.93
-0.76
-0.59
-0.41

Details

Expected EPS
-0.649286
Actual EPS
-0.93
Surprise EPS
-0.28
Surprise Percent
-43.23%

Description

⁨Bicara Therapeutics⁩ (⁦BCAX⁩) has reported earnings of ⁦-0.93⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts